Merz L, Winter K, Richter S, Kallendrusch S, Horn A, Grunewald S
Adipocyte. 2025; 14(1):2468275.
PMID: 39962643
PMC: 11844927.
DOI: 10.1080/21623945.2025.2468275.
Takatani H, Fujita N, Imai F, Yoshida Y
eNeuro. 2025; 12(3).
PMID: 39919817
PMC: 11881905.
DOI: 10.1523/ENEURO.0359-24.2025.
Jun H, Paulo J, Appleman V, Yaron-Barir T, Johnson J, Yeo A
iScience. 2024; 27(12):111278.
PMID: 39660053
PMC: 11629276.
DOI: 10.1016/j.isci.2024.111278.
Rodrigues Sousa E, de Brot S, Zoni E, Zeinali S, Brunello A, Scarpa M
Oncogene. 2024; 44(7):462-475.
PMID: 39592836
PMC: 11810784.
DOI: 10.1038/s41388-024-03230-x.
Pryce B, Oles A, Talbert E, Romeo M, Vaena S, Sharma S
Cell Rep. 2024; 43(11):114925.
PMID: 39475511
PMC: 11774514.
DOI: 10.1016/j.celrep.2024.114925.
Development of a novel immunocompetent murine tumor model for urothelial carcinoma using in vivo electroporation.
Soleder S, Gengenbacher N, Mogler C, Eckstein M, Runge A, Kriegmair M
Sci Rep. 2024; 14(1):25619.
PMID: 39463382
PMC: 11514157.
DOI: 10.1038/s41598-024-77178-z.
Local glycolysis supports injury-induced axonal regeneration.
Masin L, Bergmans S, Van Dyck A, Farrow K, De Groef L, Moons L
J Cell Biol. 2024; 223(12).
PMID: 39352499
PMC: 11451009.
DOI: 10.1083/jcb.202402133.
Multivariate analysis of metabolic state vulnerabilities across diverse cancer contexts reveals synthetically lethal associations.
Abecunas C, Kidd A, Jiang Y, Zong H, Fallahi-Sichani M
Cell Rep. 2024; 43(10):114775.
PMID: 39305483
PMC: 11511630.
DOI: 10.1016/j.celrep.2024.114775.
PTEN acts as a crucial inflammatory checkpoint controlling TLR9/IL-6 axis in B cells.
Tsai P, Chen M, Hsu W, Lin S, Chan P, Chen H
iScience. 2024; 27(7):110388.
PMID: 39092178
PMC: 11292540.
DOI: 10.1016/j.isci.2024.110388.
SMYD5 methylation of rpL40 links ribosomal output to gastric cancer.
Park J, Wu J, Szkop K, Jeong J, Jovanovic P, Husmann D
Nature. 2024; 632(8025):656-663.
PMID: 39048817
PMC: 11625416.
DOI: 10.1038/s41586-024-07718-0.
Identification of genes that promote PI3K pathway activation and prostate tumour formation.
Francis J, Capper A, Rust A, Ferro K, Ning J, Yuan W
Oncogene. 2024; 43(24):1824-1835.
PMID: 38654106
PMC: 11164682.
DOI: 10.1038/s41388-024-03028-x.
Combined deletion of MEN1, ATRX and PTEN triggers development of high-grade pancreatic neuroendocrine tumors in mice.
Fuentes M, Lu X, Flores N, Hausmann S, Mazur P
Sci Rep. 2024; 14(1):8510.
PMID: 38609433
PMC: 11014914.
DOI: 10.1038/s41598-024-58874-2.
Phosphatase and Tensin Homolog Inhibition in Proteolipid Protein 1-Expressing Cells Stimulates Neurogenesis and Gliogenesis in the Postnatal Enteric Nervous System.
Woods C, Flockton A, Belkind-Gerson J
Biomolecules. 2024; 14(3).
PMID: 38540765
PMC: 10967813.
DOI: 10.3390/biom14030346.
Pten knockout in mouse preosteoblasts leads to changes in bone turnover and strength.
Lorenz J, Richter S, Kirstein A, Kolbig F, Nebe M, Schulze M
JBMR Plus. 2024; 8(3):ziad016.
PMID: 38505222
PMC: 10945711.
DOI: 10.1093/jbmrpl/ziad016.
PTEN deficiency induces an extrahepatic cholangitis-cholangiocarcinoma continuum via aurora kinase A in mice.
Yang Y, Wang J, Wan J, Cheng Q, Cheng Z, Zhou X
J Hepatol. 2024; 81(1):120-134.
PMID: 38428643
PMC: 11259013.
DOI: 10.1016/j.jhep.2024.02.018.
Distinct mesenchymal cell states mediate prostate cancer progression.
Pakula H, Omar M, Carelli R, Pederzoli F, Fanelli G, Pannellini T
Nat Commun. 2024; 15(1):363.
PMID: 38191471
PMC: 10774315.
DOI: 10.1038/s41467-023-44210-1.
Multivariate analysis of metabolic state vulnerabilities across diverse cancer contexts reveals synthetically lethal associations.
Abecunas C, Kidd A, Jiang Y, Zong H, Fallahi-Sichani M
bioRxiv. 2023; .
PMID: 38076921
PMC: 10705426.
DOI: 10.1101/2023.11.28.569098.
Persistent organic pollutants promote aggressiveness in prostate cancer.
Bunay J, Kossai M, Damon-Soubeyrant C, De Haze A, Saru J, Trousson A
Oncogene. 2023; 42(38):2854-2867.
PMID: 37587334
DOI: 10.1038/s41388-023-02788-2.
Neuropathological signatures revealed by transcriptomic and proteomic analysis in Pten-deficient mouse models.
Cheung S, Kwok J, Or P, Wong C, Feng B, Choy K
Sci Rep. 2023; 13(1):6763.
PMID: 37185447
PMC: 10130134.
DOI: 10.1038/s41598-023-33869-7.
Driver Mutations Dictate the Immunologic Landscape and Response to Checkpoint Immunotherapy of Glioblastoma.
Yeo A, Shah R, Aliazis K, Pal R, Xu T, Zhang P
Cancer Immunol Res. 2023; 11(5):629-645.
PMID: 36881002
PMC: 10155040.
DOI: 10.1158/2326-6066.CIR-22-0655.
